AlloSkin™ meshed human skin allograft (dermal and epidermal) is extensively tested, cleaned, and cryopreserved for cell viability. Contains extracellular matrix proteins, glycosaminoglycans, cytokines, and other natural vulnerary compounds that may interact to promote wound healing.
• Pliable, stretchable tissue allows graft contouring to wound topography
• Robust enough to suture or staple without tearing
• Meshing encourages fluid drainage from wound
AlloSkin™ can be used in a homologous fashion on any skin defect and is appropriate for use in traumatic and chronic wounds, including those where substructures such as bone, ligament, nerve, or muscle are exposed.
Contraindicated for use when gross infection at the transplantation site is present.
As with all biological products, the tissue in AlloSkin™ has the potential to transmit infectious agents despite processing treatments, extensive donor screening, tissue selection, and laboratory tests. See package insert for full listing.
Inherent uncertainty exists in medical and social histories and laboratory testing which may not detect known or unknown pathogens. Therefore, the following complications may occur with tissue transplantation: loss of integrity of transplanted tissue, immune response to transplanted tissue, transmission of known pathogens, and transmission or causation of disease of unknown etiology and characteristics. Adverse outcomes potentially attributable to AlloSkin™ must be promptly reported to the manufacturer. See package insert for full listing.
AlloSkin™ is cryopreserved and should be stored at or below -40°C. Shelf life of 5 years.
Acute Wounds
Burns
Chronic Wounds
Dehisced Wounds
Diabetic Foot
Granulating/Epithelializing Wounds
Non/Minimally Exudating Wounds
Pressure Ulcers
Surgical Wounds
Venous Ulcers
Ensure wound is adequately debrided and free of infection. Thaw in sterile isotonic solution for a minimum of 1 to 5 minutes. Affix AlloSkin™ graft per physician preference: can be stapled, sutured, glued, or tacked.
Inspect wound weekly, sooner if deemed necessary, to determine if AlloSkin™ is still in place or beginning to slough. Tissue generally sloughs in 7-14 days as wound bed granulation proceeds. Depending on wound assessment, clinician may leave graft in place. Additional applications are used if satisfactory closure has not been achieved with initial application. Typical wounds close with 1 to 3 applications.
Apply any combination of non-adherent sterile dressing over AlloSkin™.
Non-cytotoxic
No posters match your selected filters. Remove some filtres, or reset them and start again.
Be included in the most comprehensive wound care products directory
and online database.
Learn More